176 related articles for article (PubMed ID: 34743742)
1. The role of vulpinic acid as a natural compound in the regulation of breast cancer-associated miRNAs.
Cansaran-Duman D; Yangın S; Çolak B
Biol Res; 2021 Nov; 54(1):37. PubMed ID: 34743742
[TBL] [Abstract][Full Text] [Related]
2. Determination of Vulpinic Acid Effect on Apoptosis and mRNA Expression Levels in Breast Cancer Cell Lines.
Kılıç N; Aras S; Cansaran-Duman D
Anticancer Agents Med Chem; 2018; 18(14):2032-2041. PubMed ID: 30179144
[TBL] [Abstract][Full Text] [Related]
3. MiR-222 and miR-29a contribute to the drug-resistance of breast cancer cells.
Zhong S; Li W; Chen Z; Xu J; Zhao J
Gene; 2013 Nov; 531(1):8-14. PubMed ID: 23994196
[TBL] [Abstract][Full Text] [Related]
4. Antiproliferative, antimigratory, and apoptotic effects of diffractaic and vulpinic acids as thioredoxin reductase 1 inhibitors on cervical cancer.
Budak B; Kalın ŞN; Yapça ÖE
Naunyn Schmiedebergs Arch Pharmacol; 2024 Mar; 397(3):1525-1535. PubMed ID: 37658214
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of thioredoxin reductase 1 by vulpinic acid suppresses the proliferation and migration of human breast carcinoma.
Kalın ŞN; Altay A; Budak H
Life Sci; 2022 Dec; 310():121093. PubMed ID: 36270425
[TBL] [Abstract][Full Text] [Related]
6. miRNA expression patterns in chemoresistant breast cancer tissues.
Lv J; Xia K; Xu P; Sun E; Ma J; Gao S; Zhou Q; Zhang M; Wang F; Chen F; Zhou P; Fu Z; Xie H
Biomed Pharmacother; 2014 Oct; 68(8):935-42. PubMed ID: 25451164
[TBL] [Abstract][Full Text] [Related]
7. Induction of Apoptosis and Regulation of MicroRNA Expression by (2
Yeap SK; Mohd Ali N; Akhtar MN; Razak NA; Chong ZX; Ho WY; Boo L; Zareen S; Kurniawan TA; Avtar R; Ng SYL; Ong AHK; Alitheen NB
Molecules; 2021 Feb; 26(5):. PubMed ID: 33652854
[TBL] [Abstract][Full Text] [Related]
8. Integrated analysis of mRNA and miRNA profiles revealed the role of miR-193 and miR-210 as potential regulatory biomarkers in different molecular subtypes of breast cancer.
Evangelista AF; Oliveira RJ; O Silva VA; D C Vieira RA; Reis RM; C Marques MM
BMC Cancer; 2021 Jan; 21(1):76. PubMed ID: 33461524
[TBL] [Abstract][Full Text] [Related]
9. Effect of Turkish Propolis on miRNA Expression, Cell Cycle, and Apoptosis in Human Breast Cancer (MCF-7) Cells.
Misir S; Aliyazicioglu Y; Demir S; Turan I; Hepokur C
Nutr Cancer; 2020; 72(1):133-145. PubMed ID: 31112051
[TBL] [Abstract][Full Text] [Related]
10. Determination of Dysregulated miRNA Expression Levels by qRT-PCR after the Application of Usnic Acid to Breast Cancer.
Tanman Ü; Yangın S; Cansaran-Duman D
Anticancer Agents Med Chem; 2020; 20(5):548-558. PubMed ID: 31549595
[TBL] [Abstract][Full Text] [Related]
11. miRNA-223 suppresses FOXO1 and functions as a potential tumor marker in breast cancer.
Wei YT; Guo DW; Hou XZ; Jiang DQ
Cell Mol Biol (Noisy-le-grand); 2017 May; 63(5):113-118. PubMed ID: 28719355
[TBL] [Abstract][Full Text] [Related]
12. Can the microRNA expression profile help to identify novel targets for zoledronic acid in breast cancer?
Fanale D; Amodeo V; Bazan V; Insalaco L; Incorvaia L; Barraco N; Castiglia M; Rizzo S; Santini D; Giordano A; Castorina S; Russo A
Oncotarget; 2016 May; 7(20):29321-32. PubMed ID: 27081088
[TBL] [Abstract][Full Text] [Related]
13. Alterations of microRNAs are associated with impaired growth of MCF-7 breast cancer cells induced by inhibition of casein kinase 2.
Li D; Chen L; Hu Z; Li H; Li J; Wei C; Huang Y; Song H; Fang L
Int J Clin Exp Pathol; 2014; 7(7):4008-15. PubMed ID: 25120778
[TBL] [Abstract][Full Text] [Related]
14. Marine fungal metabolite 1386A alters the microRNA profile in MCF-7 breast cancer cells.
Tang B; He WL; Zheng C; Cheang TY; Zhang XF; Wu H; Yang HL
Mol Med Rep; 2012 Mar; 5(3):610-8. PubMed ID: 22159329
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-125b upregulation confers aromatase inhibitor resistance and is a novel marker of poor prognosis in breast cancer.
Vilquin P; Donini CF; Villedieu M; Grisard E; Corbo L; Bachelot T; Vendrell JA; Cohen PA
Breast Cancer Res; 2015 Jan; 17(1):13. PubMed ID: 25633049
[TBL] [Abstract][Full Text] [Related]
16. Etoposide-induced MicroRNA-205-5p Suppresses Proliferation and Migration by Targeting ERBB4 in MCF-7 Cells.
Son SW; Heo SH; Oh SS; Lee CH; Park JK
Anticancer Res; 2022 Sep; 42(9):4265-4272. PubMed ID: 36039421
[TBL] [Abstract][Full Text] [Related]
17. miRNA-34a is associated with docetaxel resistance in human breast cancer cells.
Kastl L; Brown I; Schofield AC
Breast Cancer Res Treat; 2012 Jan; 131(2):445-54. PubMed ID: 21399894
[TBL] [Abstract][Full Text] [Related]
18. microRNA-335 inhibits proliferation, cell-cycle progression, colony formation, and invasion via targeting PAX6 in breast cancer cells.
Meng Y; Zou Q; Liu T; Cai X; Huang Y; Pan J
Mol Med Rep; 2015 Jan; 11(1):379-85. PubMed ID: 25323813
[TBL] [Abstract][Full Text] [Related]
19. Lipoic acid alters the microRNA signature in breast cancer cells.
Khalife H; Fayyad-Kazan M; Fayyad-Kazan H; Hadchity E; Borghol N; Hussein N; Badran B
Pathol Res Pract; 2024 May; 257():155321. PubMed ID: 38678851
[TBL] [Abstract][Full Text] [Related]
20. β-elemene reverses chemoresistance of breast cancer via regulating MDR-related microRNA expression.
Zhang J; Zhang Hd; Chen L; Sun DW; Mao Cf; Chen W; Wu JZ; Zhong SL; Zhao JH; Tang JH
Cell Physiol Biochem; 2014; 34(6):2027-37. PubMed ID: 25562151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
